Kourosh Harounian, DPM
Primary Podiatric Medicine · Los Angeles, CANPI 1730269655
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 41 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 12 manufacturers reported payments, led by Amgen at 42.7% of the total. Reporting peaked in 2024 at $469 and has fallen 54.3% since, to $214 in 2025. That places this record below the midpoint for primary podiatric medicine clinicians in CA, where the typical reported total is $887.
Across 41 payments — averaging $27.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$474
- Paratek Pharmaceuticals, Inc.$244
- Boston Scientific$73
- Organogenesis Inc.$56
- Ortho Dermatologics, A Division Of Bausch Health US, LLC$46
- Nevro Corp.$43
- plus $175 from 6 others
What the payments were for
- Food & beverage$1,110100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 14 | $474 |
| Paratek Pharmaceuticals, Inc. | 11 | $244 |
| Boston Scientific | 2 | $73 |
| Organogenesis Inc. | 2 | $56 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 3 | $46 |
| Nevro Corp. | 2 | $43 |
| Treace Medical Concepts, Inc. | 1 | $40 |
| Zimmer Biomet | 2 | $38 |
| Medartis Inc. | 1 | $33 |
| Bioventus LLC | 1 | $25 |
| Smith+Nephew | 1 | $20 |
| Venclose Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- KRYSTEXXA$143
How this compares
$1,110 in reported general payments places this provider in the 50th percentile of 59 primary podiatric medicine providers in California.
See all primary podiatric medicine providers in California →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CiclopiroxCiclopirox Olamine | 70 | $1,423 |
| Clotrimazole | 22 | $744 |
| Cephalexin | 27 | $127 |
| Triamcinolone Acetonide | 18 | $65 |
Paid to pharmacies, not to this prescriber.
Other primary podiatric medicine in Los Angeles
- James WangLos Angeles$250K
- David KhakshoorLos Angeles$4K
- Adam ShapiroUpland$21K
- Ali GhorbanifarajzadehBakersfield$17K
- Abid ChaudhryArleta$11K
- Matthew GarrisonSacramento$7K
- Linh HuynhTurlock$7K
- Yvette CanabaSantee$5K
- Katrina SergeevaVista$4K
- Christyn MarshallDanville$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.